Winslow Evans & Crocker’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-125	Closed	-$6K	–	1080
2020 Q2	$6K	Sell	125 -375	-75%	-$18K	﹤0.01%	829
2020 Q1	$22K	Hold	500	–	–	0.01%	553
2019 Q4	$22K	Buy	+500	New	+$21.8K	0.01%	644
2018 Q2	–	Sell	-2,100	Closed	-$47.2K	–	1124
2018 Q1	$47.2K	Sell	2,100 -650	-24%	-$18K	0.02%	490
2017 Q4	$82.8K	Sell	2,750 -1,050	-28%	-$33.6K	0.03%	400
2017 Q3	$143K	Sell	3,800 -1,300	-25%	-$42.3K	0.05%	300
2017 Q2	$142K	Hold	5,100	–	–	0.04%	369
2017 Q1	$175K	Buy	5,100 +1,600	+46%	+$56.5K	0.06%	314
2016 Q4	$101K	Buy	3,500 +1,100	+46%	+$29.1K	0.03%	404
2016 Q3	$76.3K	Sell	2,400 -2,000	-45%	-$67.8K	0.02%	455
2016 Q2	$143K	Buy	4,400 +2,400	+120%	+$80.3K	0.04%	316
2016 Q1	$55.9K	Buy	2,000 +1,000	+100%	+$21.8K	0.02%	473
2015 Q4	$35.6K	Hold	1,000	–	–	0.01%	601
2015 Q3	$33.1K	Buy	+1,000	New	+$41.6K	0.01%	588